InspireMD Company Overview
Implementing our commercial strategy: Overview
InspireMD
InspireMD is seeking to become the leading stroke prevention
company, focused on reducing the global burden of stroke
1
2
3
4
•
•
•
•
•
Transition current users of conventional carotid stents to CGuard™
Persuade current users of conventional carotid stents to switch to CGuard™
Continue to support investigator initiated clinical registries
Engage advisory board, further develop network of KOLs, establish centers of excellence
Transition Vascular Surgeons to CGuard™
Advisory boards, surgeon specific clinical registries, centers of excellence
Establish a presence at major vascular surgery meetings
Publish, present, and communicate all data demonstrating that CGuard TM is as safe as CEA
Partner with appropriate societies focused on Stroke
Expand footprint in existing geographical areas
·
•
Focus on larger growing markets - Germany, Italy, Poland
Support regional clinical and clinical specialty registries
Initiate discussions with the institutions and organizations that set clinical guidelines
Continue geographical expansion where strategically relevant
Continued focus on markets where a CE mark is already in place
•
Increase efforts in China and Japan
. Submit US IDE
20View entire presentation